docruДоктор.РуTitle1727-23782713-2994ООО "ГК "РУСМЕДИКАЛ"10.31550/1727-2378-2024-23-5-67-72docru-307Research ArticleОБЗОРЫREVIEWSОптико-электронная технология: достаточная альтернатива или необходимая помощь в скрининге рака шейки матки?Оptoelectronic Technology: a Sufficient Alternative or a Necessary Aid in Cervical Cancer Screening?БуйняковаА. И.BuinyakovaA. I.

Буйнякова Анна Игоревна — к. м. н., онколог, советник генерального директора по медицинским вопросам

191124, г. Санкт-Петербург., ул. Новгородская, д. 23

23 Novgorodskaya Str., Saint Petersburg, 191124

a.buiniakova@intelmed.ruАО «Интелмед»РоссияIMSystemsRussian Federation202420022025235ГИНЕКОЛОГИЯ6772Copyright © Буйнякова А.И., 20252025Буйнякова А.И.Buinyakova A.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://docru.elpub.ru/jour/article/view/307Цель обзора

Цель обзора. Рассмотреть преимущества и недостатки применения метода оптико-электронного скрининга состояния шейки матки для выявления цервикальных интраэпителиальных неоплазий и рака шейки матки.

Основные положения

Основные положения. На современном этапе применение оптико-электронного сканирования крайне важно для наилучшей диагностики предраковых заболеваний шейки матки. Оно может помочь снизить заболеваемость раком шейки матки и благотворно отразиться на здоровье женщин.

Заключение

Заключение. Оптико-электронная технология обеспечивает чувствительность, сопоставимую с таковой жидкостного цитологического исследования микропрепарата шейки матки, и может использоваться как в качестве метода первичного скрининга, так и для отбора пациенток с положительным результатом ВПЧ-тестирования на дальнейшие диагностические и лечебные мероприятия.

Aim

Aim. To review the advantages and disadvantages of using an optoelectronic cervical screening method to detect cervical intraepithelial neoplasia and cervical cancer.

Key points

Key points. At the present stage, the use of optical-electronic scanning is extremely important for the best diagnosis of cervical precancerous lesions. It can help to reduce the incidence of cervical cancer and will benefit the health of women.

Conclusion

Conclusion. The optoelectronic technology provides sensitivity comparable to that of liquid cytologic examination of cervical micro specimens and can be used both as a primary screening method and for selection of HPV-positive patients for further diagnostic and therapeutic measures.

рак шейки маткивирус папилломы человекацервикальные интраэпителиальные неоплазииоптико-электронный метод скринингаcervical cancerhuman papillomaviruscervical intraepithelial neoplasiaoptoelectronic screening methodReferencesКаприн А.Д., Старинский В.В., Шахзадова А.О., ред. Состояние онкологической помощи населению России в 2023 году. М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2024. 262 с.Kaprin A.D., Starinsky V.V., Shakhzadova A.O., eds. The state of oncologic assistance to the Russian population in 2023. M.: P.A. Herzen Moscow Research Institute of Oncology — a department of the Federal State Budgetary Institution NMRC of Radiology; 2024. 262 р. (in Russian)Волченко Н.Н., Борисова О.В. Ошибки цитологической диагностики заболеваний шейки матки. Новости клинической цитологии России. 2020;24(1):17–22. DOI: 10.24411/1562-4943-2020-10103Volchenko N.N., Borisova O.V. Errors in cervical cytological diagnostics. Russian News of Clinical Cytology. 2020;24(1):17–22. DOI: 10.24411/1562-4943-2020-10103Артымук Н.В. Цервикальный скрининг. Доктор.Ру. 2021;20(1):56–60. DOI: 10.31550/1727-2378-2021-20-1-56-60Artymuk N.V. Cervical screening. Doctor.Ru. 2021;20(1):56–60. (in Russian). DOI: 10.31550/1727-2378-2021-20-1-56-60Шабалова И.П., Касоян К.Т., ред. Цитология жидкостная и традиционная при заболеваниях шейки матки. Цитологический атлас. М.; 2016. 320 с.Shabalova I.P., Kasoyan K.T., eds. Liquid and conventional cytology in cervical diseases. A cytologic atlas. M.; 2016. 320 p. (in Russian)Koliopoulos G., Nyaga V.N., Santesso N., Bryant A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 2017;8(8):CD008587. DOI: 10.1002/14651858.CD008587.pub2Koliopoulos G., Nyaga V.N., Santesso N., Bryant A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 2017;8(8):CD008587. DOI: 10.1002/14651858.CD008587.pub2Quek S.C., Mould T., Canfell K., Singer A. et al. The Polarprobe emerging technology for cervical cancer screening. Ann. Acad. Med. Singap. 1998;27(5):717–21.Quek S.C., Mould T., Canfell K., Singer A. et al. The Polarprobe emerging technology for cervical cancer screening. Ann. Acad. Med. Singap. 1998;27(5):717–21.Özdemir H., Şerbetçioğlu G.Ç., Ayhan A. New screening method for cervical cancer — Polar Probe. Dicle Med. J. 2020;47(3):587–95.Özdemir H., Şerbetçioğlu G.Ç., Ayhan A. New screening method for cervical cancer — Polar Probe. Dicle Med. J. 2020;47(3):587–95.Suchońska B., Gajzlerska-Majewska W., Wielgoś M. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations PLoS One. 2021;16(2):e0247702. DOI: 10.1371/journal.pone.0247702Suchońska B., Gajzlerska-Majewska W., Wielgoś M. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations PLoS One. 2021;16(2):e0247702. DOI: 10.1371/journal.pone.0247702Yang H., Zhang X., Hao Z. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening A PRISMA-compliant systematic review and meta-analysis. Medicine. 2018;97:e11439. DOI: 10.1097/MD.0000000000011439 PMID: 30024517Yang H., Zhang X., Hao Z. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening A PRISMA-compliant systematic review and meta-analysis. Medicine. 2018;97:e11439. DOI: 10.1097/MD.0000000000011439 PMID: 30024517Lee S.J., Bae J.H., Kim J.H., Lee S.H. et al. A real-time optoelectronic device in screening of cervical intraepithelial neoplasia. J. Womens Med. 2009;2:23–8.Lee S.J., Bae J.H., Kim J.H., Lee S.H. et al. A real-time optoelectronic device in screening of cervical intraepithelial neoplasia. J. Womens Med. 2009;2:23–8.Chen F., Zhang G., Cui M., Zhang Y. et al. Evaluation of the effectiveness of an all powered optoelectronic technology in cancer screening. From TruScreen International Virtual Symposium with Australia, China, Zimbabwe, Saudi Arabia and the Russian Federation. 2023.Chen F., Zhang G., Cui M., Zhang Y. et al. Evaluation of the effectiveness of an all powered optoelectronic technology in cancer screening. From TruScreen International Virtual Symposium with Australia, China, Zimbabwe, Saudi Arabia and the Russian Federation. 2023.Vet J.N.I., Haindl J.P., Velasquez C., Parker L.J. et al. A performance evaluation of an optoelectronic cervical screening device in comparison to cytology and HPV DNA testing. Eur. J. Gynaecol. Oncol. 2022;43(2):213–18.Vet J.N.I., Haindl J.P., Velasquez C., Parker L.J. et al. A performance evaluation of an optoelectronic cervical screening device in comparison to cytology and HPV DNA testing. Eur. J. Gynaecol. Oncol. 2022;43(2):213–18.Yang X., He L., Xiao X., Yan L. et al. Effectiveness of TruScreen for detecting CIN II+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Future Oncol. 2023;19(37):2493–504. DOI: 10.2217/fon-2023-0297Yang X., He L., Xiao X., Yan L. et al. Effectiveness of TruScreen for detecting CIN II+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Future Oncol. 2023;19(37):2493–504. DOI: 10.2217/fon-2023-0297Yang Y., Xu L., Yuan S., Lv J. et al. Optimal screening and detection strategies for cervical lesions: a retrospective study. J. Cancer. 2024;15(11):3612–24. DOI: 10.7150/jca.96128Yang Y., Xu L., Yuan S., Lv J. et al. Optimal screening and detection strategies for cervical lesions: a retrospective study. J. Cancer. 2024;15(11):3612–24. DOI: 10.7150/jca.96128Зароченцева Н.В., Белая Ю.М. Заболевания шейки матки у молодых женщин. Вопросы практической кольпоскопии. Генитальные инфекции. 2023;1:32–7. DOI: 10.46393/27826392_2023_1_32Zarochentseva N.V., Belaya Yu.M. Cervical diseases in young women. Issues of practical colposcopy. Genital Infections. 2023;1:32–7. DOI: 10.46393/27826392_2023_1_32Ma Y., Di J., Bi H., Zhao Q. et al. Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: a real-world study based on population screening of cervical cancer in rural areas of China. PLoS One. 2020;15(7):e0233986. DOI: 10.1371/journal.pone.0233986Ma Y., Di J., Bi H., Zhao Q. et al. Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: a real-world study based on population screening of cervical cancer in rural areas of China. PLoS One. 2020;15(7):e0233986. DOI: 10.1371/journal.pone.0233986Wei Y., Wang W., Cheng M., Hong Z. et al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;266:182–6. DOI: 10.1016/j.ejogrb.2021.09.027Wei Y., Wang W., Cheng M., Hong Z. et al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;266:182–6. DOI: 10.1016/j.ejogrb.2021.09.027

The authors declare that there are no conflicts of interest present.